BR100 Increased By (0.08%)
BR30 Increased By (0.5%)
KSE100 Increased By (0.31%)
KSE30 Increased By (0.4%)
AGHA 6.41 Increased By ▲ 0.09 (1.42%)
BECO 4.35 Increased By ▲ 0.08 (1.87%)
BML 63.00 Increased By ▲ 0.55 (0.88%)
BOP 31.50 Increased By ▲ 0.27 (0.86%)
CNERGY 11.68 Increased By ▲ 0.09 (0.78%)
CSIL 5.88 Increased By ▲ 0.16 (2.8%)
FCCL 60.84 Decreased By ▼ -0.70 (-1.14%)
FFL 14.77 Decreased By ▼ -0.25 (-1.66%)
FNEL 1.22 Decreased By ▼ -0.01 (-0.81%)
KEL 6.33 Increased By ▲ 0.07 (1.12%)
KOSM 5.94 Increased By ▲ 0.38 (6.83%)
LOTCHEM 24.71 Increased By ▲ 0.03 (0.12%)
MLCF 103.50 Decreased By ▼ -0.58 (-0.56%)
NBP 173.10 Decreased By ▼ -2.18 (-1.24%)
NCPL 52.30 Decreased By ▼ -0.47 (-0.89%)
NPL 54.10 Decreased By ▼ -0.02 (-0.04%)
OGDC 316.80 Increased By ▲ 3.41 (1.09%)
PACE 9.20 No Change ▼ 0.00 (0%)
PAEL 35.85 Increased By ▲ 0.05 (0.14%)
PIBTL 13.61 Increased By ▲ 0.14 (1.04%)
PPL 226.58 Increased By ▲ 4.77 (2.15%)
PRL 80.60 Increased By ▲ 1.52 (1.92%)
PTC 46.99 Increased By ▲ 0.14 (0.3%)
SSGC 23.70 Decreased By ▼ -0.17 (-0.71%)
TBL 9.30 Decreased By ▼ -0.01 (-0.11%)
TELE 7.54 Increased By ▲ 0.15 (2.03%)
TPL 24.69 Decreased By ▼ -0.42 (-1.67%)
TPLP 12.85 Increased By ▲ 0.34 (2.72%)
TREET 26.30 Increased By ▲ 0.05 (0.19%)
TRG 53.38 Decreased By ▼ -0.06 (-0.11%)
Markets

CBOT soybeans to rise to $12.80-3/4; momentum sufficient

Published Updated
By

SINGAPORE: The CBOT soybean January contract may rise to $12.80-3/4, as it has broken a resistance at $12.68-1/4 per bushel.

The contract is riding on a wave c, which started at $12.14-1/4. It is capable of travelling into a range of $12.80-3/4 to $13.22-1/4.

After a few days of consolidation, the contract eventually accumulated enough momentum to break $12.68-1/4 and rise towards the target zone.

Support is at $12.55-1/2, a break below which may cause a fall to $12.39-1/2. On the daily chart, the contract remains firm above a support at $12.51-1/2.

Chances are it may climb to $12.94-3/4, the 38.2% retracement of the downtrend from $14.79.

Each reader should consult his or her own professional or other advisers for business, financial or legal advice regarding the products mentioned in the analyses.

Comments

Comments are closed for this article.